Certified by Founder Lodge
Syntis Bio

START UP
1 Disclosed Funding Rounds $38,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Syntis Bio is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine’s unique biology to provide accessible, effective and sustainable solutions
Date | Round | Raised | Participating Investors |
---|---|---|---|
July, 02 ,2025 | Series A | $38,000,000 |